七月 2026
- Home
- Outcomes Matter Innovations
七月 2026的Outcomes Matter Innovations市场份额分析
Whether you’re looking to learn more about our services or have a specific inquiry, our team is here to help. Reach out to us today, and let’s start a
Outcomes Matter Innovations(包含公司地区分支机构)
查看更多网站流量和参与度信息- omimanagement.com
Outcomes Matter Innovations收入截至 七月 2026为 1M - 2M
Outcomes Matter Innovations主要域名产生的收入
3 年中Outcomes Matter Innovations主要域名的收入
Outcomes Matter Innovations主要域名的收入
Outcomes Matter Innovations热门域名的总访问量
了解Outcomes Matter Innovations市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
Outcomes Matter Innovations热门域名的平均访问时长
分析Outcomes Matter Innovations参与度指标。
过去 3 个月的平均访问时长
子公司明细
Outcomes Matter Innovations热门域名的平均页面浏览量
了解Outcomes Matter Innovations如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
Outcomes Matter Innovations 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻Outcomes Matter Innovations, LLC hires Christopher Windham as Executive Chief Operating Officer and Chief Clinical Officer.Outcomes Matter Innovations, LLC is pleased to announce that OMI has appointed Dr. Christopher Windham as Executive Chief Operating Officer and Chief Clinical Officer.
一月 13, 2026阅读更多
新闻Outcomes Matter Innovations, LLC launches Value-Based Care oncology program.Outcomes Matter Innovations launches their Value-Based Care oncology program by partnering with Regional Cancer Care Associates (RCCA).
十一月 13, 2025阅读更多
新闻Outcomes Matter Innovations, LLC partnered with Regional Cancer Care Associates, LLC on Jan 9th '25.Outcomes Matter Innovations (OMI) today announced a co-development agreement with Regional Cancer Care Associates (RCCA), the largest by volume provider of cancer services in New Jersey and a leader in providing all forms of innovative cancer care in an NCI designated consortium university academic setting and in the community throughout New Jersey, Connecticut, Maryland, Massachusetts and D.C.
一月 9, 2025阅读更多
查看 Outcomes Matter Innovations 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。
